SIRO Clinpharm seeks Asia Pacific growth with DreamCIS pact
Mumbai-based contract research organisation SIRO Clinpharm has formed an alliance with DreamCIS, a CRO based in Seoul, South Korea in order to build its business in the Asia Pacific region.
Mumbai-based contract research organisation SIRO Clinpharm has formed an alliance with DreamCIS, a CRO based in Seoul, South Korea in order to build its business in the Asia Pacific region.
DreamCIS has nearly a decade of experience in offering clinical research services to pharmaceutical companies and medical device manufacturers. Services include clinical trial management, pharmacovigilance, post marketing surveillance, data management, biostatistics and quality assurance services.
SIRO, which has a presence in India, Europe, and the US, has been involved in clinical research for 14 years and in addition to the services above, offers medical writing, clinical trials supplies management, feasibility and patient planning.
"Our goal is to offer a wider platform of patient recruitment capabilities from the Asia Pac region for our global client base," said Ajit Nair, Siro's president in India.
